BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37574315)

  • 1. [The mechanism of berberine on Methicillin resistant
    Zhou FF; Gu XM; Wang L; Lin M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Aug; 57(8):1217-1221. PubMed ID: 37574315
    [No Abstract]   [Full Text] [Related]  

  • 2. The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Li X; Wang P; Hu X; Zhang Y; Lu X; Li C; Nie T; Li G; Wang X; Pang J; Lu Y; Yang X; You X
    BMC Microbiol; 2020 Oct; 20(1):317. PubMed ID: 33076836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Liang RM; Yong XL; Duan YQ; Tan YH; Zeng P; Zhou ZY; Jiang Y; Wang SH; Jiang YP; Huang XC; Dong ZH; Hu TT; Shi HQ; Li N
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2861-9. PubMed ID: 25108628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibacterial mechanism of oridonin against methicillin-resistant
    Yuan Z; Ouyang P; Gu K; Rehman T; Zhang T; Yin Z; Fu H; Lin J; He C; Shu G; Liang X; Yuan Z; Song X; Li L; Zou Y; Yin L
    Pharm Biol; 2019 Dec; 57(1):710-716. PubMed ID: 31622118
    [No Abstract]   [Full Text] [Related]  

  • 5. Gold nanoparticle conjugation enhances berberine's antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Sadeghi S; Agharazi F; Hosseinzadeh SA; Mashayekhi M; Saffari Z; Shafiei M; Nader Shahrokhi ; Ebrahimi-Rad M; Sadeghi M
    Talanta; 2024 Feb; 268(Pt 1):125358. PubMed ID: 37918244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembled Nanoparticles of Natural Phytochemicals (Berberine and 3,4,5-Methoxycinnamic Acid) Originated from Traditional Chinese Medicine for Inhibiting Multidrug-Resistant Staphylococcus aureus.
    Han N; Huang X; Tian X; Li T; Liu X; Li W; Huo S; Wu Q; Gu Y; Dai Z; Xu B; Wang P; Lei H
    Curr Drug Deliv; 2021; 18(7):914-921. PubMed ID: 33234104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total flavonoids from Potentilla kleiniana Wight et Arn inhibits biofilm formation and virulence factors production in methicillin-resistant Staphylococcus aureus (MRSA).
    Tao J; Yan S; Zhou C; Liu Q; Zhu H; Wen Z
    J Ethnopharmacol; 2021 Oct; 279():114383. PubMed ID: 34214645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine and chlorogenic acid-assembled nanoparticles for highly efficient inhibition of multidrug-resistant Staphylococcus aureus.
    Fu S; Yi X; Li Y; Li Y; Qu X; Miao P; Xu Y
    J Hazard Mater; 2024 Jul; 473():134680. PubMed ID: 38795486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).
    Aruldass CA; Masalamany SRL; Venil CK; Ahmad WA
    Environ Sci Pollut Res Int; 2018 Feb; 25(6):5164-5180. PubMed ID: 28361404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus.
    Akilandeswari K; Ruckmani K
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):74-82. PubMed ID: 28145860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant
    Xia S; Ma L; Wang G; Yang J; Zhang M; Wang X; Su J; Xie M
    Infect Drug Resist; 2022; 15():1933-1944. PubMed ID: 35469308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Li Y; Han J; Wang GC; Zhang YL; Bian ZQ
    Molecules; 2012 Aug; 17(9):10322-30. PubMed ID: 22932213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-assembled nanocomplexes comprising epigallocatechin gallate and berberine for enhanced antibacterial activity against multidrug resistant Staphylococcus aureus.
    Zheng T; Cui M; Chen H; Wang J; Ye H; Zhang Q; Sun S; Feng Y; Zhang Y; Liu W; Chen R; Li Y; Dong Z
    Biomed Pharmacother; 2023 Jul; 163():114856. PubMed ID: 37196539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro profiling of antimethicillin-resistant Staphylococcus aureus activity of thymoquinone against selected type and clinical strains.
    Hariharan P; Paul-Satyaseela M; Gnanamani A
    Lett Appl Microbiol; 2016 Mar; 62(3):283-9. PubMed ID: 26743923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial liposomes of berberine and curcumin inhibit biofilm formation and intracellular methicillin resistant
    Bhatia E; Sharma S; Jadhav K; Banerjee R
    J Mater Chem B; 2021 Jan; 9(3):864-875. PubMed ID: 33392614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of plumbagin isolated from Plumbago zeylanica L. against methicillin-resistant Staphylococcus aureus.
    Periasamy H; Iswarya S; Pavithra N; Senthilnathan S; Gnanamani A
    Lett Appl Microbiol; 2019 Jul; 69(1):41-49. PubMed ID: 31044446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
    Chu M; Zhang MB; Liu YC; Kang JR; Chu ZY; Yin KL; Ding LY; Ding R; Xiao RX; Yin YN; Liu XY; Wang YD
    Sci Rep; 2016 Apr; 6():24748. PubMed ID: 27103062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba exocarp extracts inhibit S. aureus and MRSA by disrupting biofilms and affecting gene expression.
    Wang B; Wei PW; Wan S; Yao Y; Song CR; Song PP; Xu GB; Hu ZQ; Zeng Z; Wang C; Liu HM
    J Ethnopharmacol; 2021 May; 271():113895. PubMed ID: 33524512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance of vancomycin minimum inhibitory concentration for methicillin-resistant Staphylococcus aureus at 2 
    Kuo CF; Lio CF; Chen HT; Wang YT; Ma KS; Chou YT; Chang FC; Tsai SY
    PeerJ; 2020; 8():e8963. PubMed ID: 32435531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
    Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
    J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.